NEW YORK: The U.S. Food and Drug Administration has approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).
Schizophrenia is a chronic, severe, and disabling brain disorder. Typically, Read More »